Company Search:
Advanced Search
Sponsored Links
BML Inc Company Snapshot
BML Inc operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other pharmaceutical manufacturers in Asia: Dr. Lal PathLabs Ltd of India (2016 sales of 7.91 billion Indian Rupees [US$118.38 million] ), Medical & Biological Laboratories Company Limited (8.06 billion Japanese Yen [US$77.34 million] of which 99% was Reagent business), and Falco Holdings Co Ltd (48.73 billion Japanese Yen [US$467.78 million] of which 59% was Medical Test).

Sales Analysis. BML Inc reported sales of ¥109.02 billion (US$1.05 billion) for the fiscal year ending March of 2016. This represents an increase of 4.4% versus 2015, when the company's sales were ¥104.40 billion. Sales at BML Inc have increased during each of the previous five years (and since 2011, sales have increased a total of 35%). Sales of Medical Information Systems Business saw an increase that was more than double the company's growth rate: sales were up 9.5% in 2016, from ¥3.61 billion to ¥3.95 billion. BML Inc also saw significant increases in sales in Other (up 6.4% to ¥1.50 billion) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for BML Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 2,825.00
(Figures in Japanese Yen)
1 Week -2.8%   13 Weeks 7.0%  
4 Weeks 12.8%   52 Weeks 61.4%  
BML Inc Key Data:
  Ticker: 4694 Country: Japan
  Exchanges: TYO Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2016 Sales 109,024,000,000
(Year Ending Jan 2017).
Employees: 4,673
  Currency: Japanese Yen Market Cap: 123,495,040,278
  Fiscal Yr Ends: March Shares Outstanding: 42,481,954
  Share Type: Common Closely Held Shares: 22,488,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.